BeStock  
Stocks › Biotechnology › SLBT

SL Science SLBT

US equityMarket cap rank #3713Biotechnology
$0.55 −$0.03 (-5.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $0.55 0.00%
Open$0.57
Prev close$0.58
Day range$0.51 – $0.57
Volume28.6K
Market cap$308.42M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-66.1x
CheapRich

Near the top of its 5-year range · 98th percentile, 5-year average -382.8x

Price / book60.6x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average 210.2x

#5270 of 5329 stocks by PB (1 = cheapest)

Price / sales166.1x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average 647.3x

#4994 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-2,403x-1,529x-655x218xJun '26Sep '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$1.08
Price vs. fair value-49.1%Trading below the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 60.58 – 210.24 3% (cheaper than usual) #5270 of 5329 (1 = cheapest)
PE -66.09 – -382.76 98% (pricier than usual) –
PS 166.08 – 647.32 3% (cheaper than usual) #4994 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on SLBT.

Sign in to join the discussion.

Scroll to Top